Loading...
Loading...
Haoxi Health Technology Ltd
Haoxi Health Technology Ltd. Spoken Alpha tracks HAO's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks HAO's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HAO.
curl https://api.spokenalpha.com/v1/companies/HAO| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.38 | $3.31 | +32.4% | +3.8% | +2.8% |
| Q4 FY2026 | $3.95 | $3.20 | +23.5% | -1.1% | -3.4% |
| Q3 FY2026 | $3.86 | $3.11 | +24.0% | +5.2% | +7.0% |
| Q2 FY2026 | $4.18 | $3.16 | +32.2% | +4.6% | +5.6% |
| Q1 FY2025 | $4.23 | $3.14 | +34.6% | +4.7% | +5.6% |
| Q4 FY2025 | $4.13 | $3.21 | +28.8% | +5.5% | +3.2% |
| Q3 FY2025 | $4.34 | $3.23 | +34.4% | +3.0% | +2.0% |
| Q2 FY2025 | $4.23 | $3.21 | +31.7% | +3.8% | +5.2% |
| Q1 FY2024 | $4.37 | $3.42 | +27.8% | -1.5% | -0.3% |
| Q4 FY2024 | $4.50 | $3.38 | +33.1% | +4.6% | +7.1% |